Protocol to request
N-((4bR,6R,8aS)−11-(Cyclopropylmethyl)−3,8a-dihydroxy-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-6-yl)−3-iodobenzamide (MP1601)
Research article
Controlling opioid receptor functional selectivity by targeting distinct subpockets of the orthosteric site
Rajendra Uprety et al.
DOI: 10.7554/eLife.56519